Original Research

Published on 20 Nov 2024

Evening cortisol levels are prognostic for progression-free survival in a prospective pilot study of head and neck cancer patients

in Cancer Immunity and Immunotherapy

Elizabeth Cash
Isak Beck
Brooks Harbison
Christy Albert
Sandra E. Sephton

Frontiers in Oncology

doi 10.3389/fonc.2024.1436996

228 views

Review

Published on 19 Nov 2024

Progress on angiogenic and antiangiogenic agents in the tumor microenvironment

in Cancer Immunity and Immunotherapy

Jian Xu

Frontiers in Oncology

doi 10.3389/fonc.2024.1491099

226 views

Editorial

Published on 19 Nov 2024

Editorial: Cell death in cancer immunology

in Cancer Immunity and Immunotherapy

Laura Mondragón
Shensi Shen
Laura Senovilla

Frontiers in Oncology

doi 10.3389/fonc.2024.1504738

138 views

Brief Research Report

Accepted on 15 Nov 2024

Association of the SNPs in CCL2 and CXCL12 genes with the susceptibility to breast cancer: a case-control study in China

in Cancer Immunity and Immunotherapy

Duanchong Zhao
Xingxing Yu
Hongli Huang
Shuqing Zou
Pingxiu Zhu
Yuxiang Lin
Mengjie Song
Fangmeng Fu
Haomin Yang

Frontiers in Oncology

doi 10.3389/fonc.2024.1475979

Review

Accepted on 14 Nov 2024

Progress of Research on PD-L1 Inhibitor Adebrelimab Usage in Malignant Tumors

in Cancer Immunity and Immunotherapy

Pan Cheng
Jichen He
Pingping Cheng
Kaixia Chen
Guangyu Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1468569

Original Research

Published on 12 Nov 2024

Characterization of the T-cell receptor repertoire associated with lymph node metastasis in colorectal cancer

in Cancer Immunity and Immunotherapy

Ya’nan Zhen
Hong Wang
Runze Jiang
Fang Wang
Cunbao Chen
Zhongfa Xu
Ruixue Xiao

Frontiers in Oncology

doi 10.3389/fonc.2024.1354533

169 views

Original Research

Published on 11 Nov 2024

CXCR6 expression predicts prognosis and immunotherapeutic benefit in muscle-invasive bladder cancer

in Cancer Immunity and Immunotherapy

Xiaolin Lu
Li-Ping Ge
Zhaopei Liu
Yu Zhu
Dingwei Ye
Yuan Chang

Frontiers in Oncology

doi 10.3389/fonc.2024.1498579

269 views

Case Report

Published on 11 Nov 2024

Reverse resistance to immune checkpoint inhibitor in a patient with recurrent cardia cancer by intratumoral injection of recombinant human adenovirus type 5: a case report and literature review

in Cancer Immunity and Immunotherapy

Qiu Zhao
Min Xiao
Jian Ma
Cong Fu
Qianqian Gao

Frontiers in Oncology

doi 10.3389/fonc.2024.1465664

228 views

Review

Accepted on 07 Nov 2024

Progress in immunotherapy for brain metastatic melanoma

in Cancer Immunity and Immunotherapy

Shicheng Zheng
Zhongqiao Lin
Ruibo Zhang
ZiHang Cheng
KaiXin Li
ChenKai Gu
Yu Chen
Jing Lin

Frontiers in Oncology

doi 10.3389/fonc.2024.1485532

Case Report

Accepted on 07 Nov 2024

Refractory hypokalemia and metabolic acidosis induced by undifferentiated connective tissue disease secondary to immune checkpoint inhibitors: a case report and literature review

in Cancer Immunity and Immunotherapy

Yinfang Gu
Lilan Yi
Xiaofang Zou
Long-Hua Guo
Guo-wu Guo
Jing-Jing Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1442605

Review

Published on 07 Nov 2024

Interactions between tumor-associated macrophages and regulated cell death: therapeutic implications in immuno-oncology

in Cancer Immunity and Immunotherapy

Yifei Ge
Lixue Jiang
Chengru Yang
Qingfu Dong
Chengwu Tang
Yi Xu
Xiangyu Zhong

Frontiers in Oncology

doi 10.3389/fonc.2024.1449696

380 views

Case Report

Accepted on 06 Nov 2024

Abscopal Effect-Induced Spontaneous Regression of Distant Metastases in Malignant Mesenchymal Tumor: A Case Report

in Cancer Immunity and Immunotherapy

Meltem Kirli Bolukbas
Cemile Ozdemir
Esengul Kocak Uzel

Frontiers in Oncology

doi 10.3389/fonc.2024.1475129

Original Research

Accepted on 05 Nov 2024

Association between smoking status, toxicity and survival in the checkpoint inhibitor immunotherapy

in Cancer Immunity and Immunotherapy

Anna Rudzińska
Pola Juchaniuk
Jakub Oberda
Kamila Krukowska
Sylwia Krzyśkowska
Eliza Kuchta
Anna Rodzajewska
Mariola Janiszewska
Katarzyna Szklener
Katarzyna Machulska- Ciuraj

Frontiers in Oncology

doi 10.3389/fonc.2024.1459608

Review

Accepted on 04 Nov 2024

Potential Predictive Biomarkers in Antitumor Immunotherapy: Navigating the Future of Antitumor Treatment and Immune Checkpoint Inhibitor Efficacy

in Cancer Immunity and Immunotherapy

Xiangyu Yin
Yunjie Song
Wanglong Deng
Neil Blake
Xinghong Luo
Jia Meng

Frontiers in Oncology

doi 10.3389/fonc.2024.1483454

Original Research

Published on 04 Nov 2024

Common molecular basis for MASH and hepatitis C revealed via systems biology approach

in Cancer Immunity and Immunotherapy

Yongwei Cheng
Zihao Song
Ye Liu
Xichao Xu
Dali Zhang
Yigui Zou
Liang Liu
Yinzhen Zeng
Wenwen Li
Daming Bai

Frontiers in Oncology

doi 10.3389/fonc.2024.1442221

331 views

Review

Published on 31 Oct 2024

Landscape of targeted therapies for lung squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Qiuxuan Chen
Xiaoshuo Zheng
Jian Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1467898

557 views

Navigation group

Articles

Evening cortisol levels are prognostic for progression-free survival in a prospective pilot study of head and neck cancer patients

Progress on angiogenic and antiangiogenic agents in the tumor microenvironment

Editorial: Cell death in cancer immunology

Association of the SNPs in CCL2 and CXCL12 genes with the susceptibility to breast cancer: a case-control study in China

Progress of Research on PD-L1 Inhibitor Adebrelimab Usage in Malignant Tumors

Characterization of the T-cell receptor repertoire associated with lymph node metastasis in colorectal cancer

CXCR6 expression predicts prognosis and immunotherapeutic benefit in muscle-invasive bladder cancer

Reverse resistance to immune checkpoint inhibitor in a patient with recurrent cardia cancer by intratumoral injection of recombinant human adenovirus type 5: a case report and literature review

Progress in immunotherapy for brain metastatic melanoma

Refractory hypokalemia and metabolic acidosis induced by undifferentiated connective tissue disease secondary to immune checkpoint inhibitors: a case report and literature review

Interactions between tumor-associated macrophages and regulated cell death: therapeutic implications in immuno-oncology

Abscopal Effect-Induced Spontaneous Regression of Distant Metastases in Malignant Mesenchymal Tumor: A Case Report

Association between smoking status, toxicity and survival in the checkpoint inhibitor immunotherapy

Potential Predictive Biomarkers in Antitumor Immunotherapy: Navigating the Future of Antitumor Treatment and Immune Checkpoint Inhibitor Efficacy

Common molecular basis for MASH and hepatitis C revealed via systems biology approach

Landscape of targeted therapies for lung squamous cell carcinoma